In the UK, medical cannabis is considered an appropriate adjunctive treatment for many patients who have been struggling to manage their seizures with conventional, traditional approaches.
This is because the chemical compounds, or cannabinoids, contained within medical cannabis are able to interact with some of the densely packed receptors in our brains and central nervous system that influence seizure onset.
It's believed that both THC and CBD, the two most prominent cannabinoids found in cannabis, can both play a supporting role in seizure management because of the biological responses they initiate after interacting with these receptors.
However, while research in this area continues, it is important that the medicinal or therapeutic application of cannabis-derived treatments is overseen and monitored by qualified healthcare professionals like those that work for Releaf for safety and efficacy reasons.
To find out if you may be considered eligible for these new options, assess your suitability for cannabis-derived seizure management treatments online now.